World renown George Clinical Physicians, Project Operations and Business Development team to exhibit (BOOTH 5009) and attend AACR Annual Meeting in Atlanta from Friday, March 29 until Wednesday, April 3, 2019.
The AACR Annual Meeting program focuses on the latest discoveries across the spectrum of cancer research—from population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy—and highlights the work of the best minds (including yours and ours) in research and medicine from institutions all over the world.
Will you be in ATL at this time? Just fill out the form below so we can invite you to join us!
Dr. Schwartzberg’s research interests include breast cancer, supportive care and developmental therapeutics. He is the Chief Medical Director of West Cancer Center and Chief of the Division of Hematology/Oncology at the University of Tennessee Health Science Center. In addition, he was appointed by the partnership, OneOncology, to Chief Medical Officer. He was recently involved with genomic profiling of advanced cancer and is interested in visionary approaches to clinical research and oncology science. He divides his time between patients in the clinic and conducting clinical research trials and programmatic development.
A renowned expert in the study and treatment of breast cancer, precision medicine and supportive care, Dr. Schwartzberg is a member of the Board of Directors for the National Comprehensive Cancer Network and is the founding editor-in-chief of the journal Community Oncology. He is also the current editor-in-chief of the Practice Update Oncology website and serves on the editorial board for both the Journal of Supportive Oncology and the ASCO Post.
Dr. VanderWalde’s research interests include immune therapies in solid tumors and melanoma. He is Director of Research at West Cancer Center; Senior Medical Director at George Clinical; and Medical Director of Precision Medicine at OneOncology. He has collaborated and participated on advisory board with many of the nation’s thought leaders and top experts in the field and previously served as United States Medical Lead and Clinical Research Medical Director with Amgen Inc., directing U.S. global development of talimogene laherparepvec, a novel viral-based immunitherapeutic that has shown efficacy in late-stage clinical trials in melanoma.
As Director of Research at West Cancer Center, Dr. VanderWalde is responsible for managing the portfolio of all clinical trials at the Cancer Center. He also serves as Medical Director of the Clinical Trials Network of Tennessee. He has been involved in research targeting therapy in a more personalized fashion based on immune markers and aberrations in cancer genetics.
Georgia World Congress Center
Meet with George Clinical! Contact us to schedule a time now.